Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib in Bronchoalveolar Carcinoma or Never-Smokers With Lung Adenocarcinoma
NCT00430261Phase 2Completed
- Sponsor
- Swedish Health Services
- Start
- Jan 2007
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib in lung adenocarcinoma, sponsored by Swedish Health Services. Started Jan 2007; status: completed.
02
Drugs
sunitinib
03
Conditions
lung adenocarcinoma
Beyond the preview
Go deeper on NCT00430261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00430261.